DERL2 (derlin 2) stabilizes BAG6 (BAG cochaperone 6) in chemotherapy resistance of cholangiocarcinoma

Luzheng Liu1, Junzhen Wu2, Yanggang Yan1, Shoucai Cheng1, Shuyong Yu3, Yong Wang4
1Department of Interventional Radiology and Vascular Surgery, The Second Affiliated Hospital of Hainan Medical University, Hainan, 570311, China.
2Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Hainan, 570311, China.
3Department of Gastrointestinal Surgery, Hainan Cancer Hospital, Hainan, China
4Department of Interventional Radiology and Vascular Surgery, The Second Affiliated Hospital of Hainan Medical University, Hainan, China

Tóm tắt

AbstractDERL2 (derlin 2) is a critical component of the endoplasmic reticulum quality control pathway system whose mutations play an important role in carcinogenesis, including cholangiocarcinoma (CHOL). However, its role and its underlying mechanism have yet to be elucidated. Herein, we revealed that DERL2 was highly expressed in CHOL and considered as an independent prognostic indicator for inferior survival in CHOL. DERL2 ectopically expressed in CHOL cells promoted cell proliferation and colony formation rates, and depleting DERL2 in CHOL cells curbed tumor growth in vitro and in vivo. More interestingly, the knockout of DERL2 augmented the growth-inhibitory effect of gemcitabine chemotherapy on CHOL cells by inducing cell apoptosis. Mechanistically, we discovered that DERL2 interacted with BAG6 (BAG cochaperone 6), thereby extending its half-life and reinforcing the oncogenic role of BAG6 in CHOL progression.

Từ khóa


Tài liệu tham khảo

Elvevi A, Laffusa A, Scaravaglio M et al (2022) Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol 27:100737

Macias RIR, Cardinale V, Kendall TJ et al (2022) Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 71:1669–1683

Izquierdo-Sanchez L, Lamarca A, La Casta A et al (2022) Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. J Hepatol 76:1109–1121

Edeline J, Touchefeu Y, Guiu B et al (2020) Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol 6:51–59

Ding GY, Ma JQ, Yun JP et al (2022) Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma. J Hepatol 76:608–618

Seeherunwong A, Chaiear N, Khuntikeo N et al (2022) Cholangiocarcinoma attributed to occupation: a systematic reviews. Asian Pac J Cancer Prev 23:1837–1845

Kamsa-Ard S, Kamsa-Ard S, Luvira V et al (2018) Risk factors for cholangiocarcinoma in Thailand: a systematic review and meta-analysis. Asian Pac J Cancer Prev 19:605–614

Skalicky P, Urban O, Ehrmann J et al (2022) The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma, vol 166. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc Czechoslovakia, pp 386–392

Chen X, Cubillos-Ruiz JR (2021) Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer 21:71–88

Qi Z, Chen L (2019) Endoplasmic reticulum stress and autophagy. Adv Exp Med Biol 1206:167–177

Song N, Song Y, Hu B et al (2023) Persistent endoplasmic reticulum stress stimulated by peptide assemblies for sensitizing cancer chemotherapy. Adv Healthc Mater 12:e2202039

Sahoo BM, Banik BK, Borah P et al (2022) Reactive oxygen species (ROS): key components in cancer therapies. Anti Cancer Agents Med Chem 22:215–222

Jiang W, Chen L, Guo X et al (2022) Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy. Theranostics 12:2987–3006

Phillips BP, Miller EA (2021) Membrane protein folding and quality control. Curr Opin Struct Biol 69:50–54

Den Brave F, Engelke J, Becker T (2021) Quality control of protein import into mitochondria. Biochem J 478:3125–3143

Pla-Prats C, Thoma NH (2022) Quality control of protein complex assembly by the ubiquitin-proteasome system. Trends Cell Biol 32:696–706

Zhou Z, Torres M, Sha H et al (2020) Endoplasmic reticulum-associated degradation regulates mitochondrial dynamics in brown adipocytes. Science 368:54–60

Krshnan L, Van De Weijer ML, Carvalho P (2022) Endoplasmic reticulum-associated protein degradation. Cold Spring Harb Perspect Biol 14

Cherepanova N, Shrimal S, Gilmore R (2016) N-linked glycosylation and homeostasis of the endoplasmic reticulum. Curr Opin Cell Biol 41:57–65

Ballar Kirmizibayrak P, Erbaykent-Tepedelen B, Gozen O et al (2020) Divergent modulation of proteostasis in prostate cancer. Adv Exp Med Biol 1233:117–151

Oakes SA (2020) Endoplasmic reticulum stress signaling in cancer cells. Am J Pathol 190:934–946

Wang Y, Wang K, Jin Y et al (2019) Endoplasmic reticulum proteostasis control and gastric cancer. Cancer Lett 449:263–271

Urra H, Dufey E, Avril T et al (2016) Endoplasmic reticulum stress and the hallmarks of cancer. Trends in cancer 2:252–262

Hetz C, Zhang K, Kaufman RJ (2020) Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 21:421–438

Zhang TM, Liao L, Yang SY et al (2023) TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression. Autophagy 19:805–821

Tan X, He X, Jiang Z et al (2015) Derlin-1 is overexpressed in human colon cancer and promotes cancer cell proliferation. Mol Cell Biochem 408:205–213

Fan J, Tian L, Huang S et al (2020) Derlin-1 promotes the progression of human hepatocellular carcinoma via the activation of AKT pathway. Onco Targets Ther 13:5407–5417

Shibata M, Kanda M, Tanaka H et al (2017) Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells. Oncol Rep 38:1760–1766

Lin L, Lin G, Lin H et al (2022) Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma. Front Immunol 13:906420

Qin W, He C, Jiang D et al (2022) Systematic construction and validation of a novel ferroptosis-related gene model for predicting prognosis in cervical cancer. J Immunol Res 2022:2148215

Dougan SK, Hu CC, Paquet ME et al (2011) Derlin-2-deficient mice reveal an essential role for protein dislocation in chondrocytes. Mol Cell Biol 31:1145–1159

Di Noto R, Pane F, Camera A et al (2001) Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma. Leukemia 15:1641–1649

Tomczak K, Czerwinska P, Wiznerowicz M (2015) The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol 19:A68–A77

Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550

Sun D, Wang J, Han Y et al (2021) TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res 49:D1420–D1430

Nusinow DP, Szpyt J, Ghandi M et al (2020) Quantitative proteomics of the cancer cell line encyclopedia. Cell 180(387-402):e316

Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 22

Van Oosterwijk JG, Buelow DR, Drenberg CD et al (2018) Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia. J Clin Invest 128:369–380

Frabutt DA, Wang B, Riaz S et al (2018) Innate sensing of influenza A virus hemagglutinin glycoproteins by the host endoplasmic reticulum (ER) stress pathway triggers a potent antiviral response via ER-associated protein degradation. J Virol 92

Tu R, Kang W, Kang Y et al (2022) c-MYC-USP49-BAG2 axis promotes proliferation and chemoresistance of colorectal cancer cells in vitro. Biochem Biophys Res Commun 607:117–123

Huang X, Shi D, Zou X et al (2023) BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate. Theranostics 13:339–354

Dong Q, Fu L, Zhao Y et al (2017) Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling. Oncotarget 8:17059–17069

Lin Y, Jiang M, Chen W et al (2019) Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response. Biomed pharmacother 118:109249

Wu J, Chen S, Liu H et al (2018) Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation. J experiment clin cancer res 37:272

Ragimbeau R, El Kebriti L, Sebti S et al (2021) BAG6 promotes PINK1 signaling pathway and is essential for mitophagy. FASEB J 35:e21361

Liao NC, Shih YL, Chou JS et al (2019) Cardamonin induces cell cycle arrest, apoptosis and alters apoptosis associated gene expression in WEHI-3 mouse leukemia cells. Am J Chin Med 47:635–656

Pattingre S, Turtoi A (2022) BAG family members as mitophagy regulators in mammals. Cells 11

Chu Y, Dong X, Kang Y et al (2020) The chaperone BAG6 regulates cellular homeostasis between autophagy and apoptosis by holding LC3B. Science 23:101708

Schuldner M, Dorsam B, Shatnyeva O et al (2019) Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53. Theranostics 9:6047–6062

Krenciute G, Liu S, Yucer N et al (2013) Nuclear BAG6-UBL4A-GET4 complex mediates DNA damage signaling and cell death. J Biol Chem 288:20547–20557

Koike K, Masuda T, Sato K et al (2022) GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein. Cancer Sci 113:156–169